Breast Cancer
Navelbine(Vinorelbine) – NSCLC | HongKong DengYue Medicine
ENHERTU (Trastuzumab Deruxtecan) – HER2-driven cancers | HongKong DengYue Medicine
Herceptin (Trastuzumab) – Breast Cancer | HongKong DengYue Medicine
Kisqali (Ribociclib) – Breast Cancer | HongKong DengYue Medicine
Truqap (Capivasertib) – Breast Cancer | HongKong DengYue Medicine
Lynparza (Olaparib) – Ovarian Cancer | HongKong DengYue Medicine
Airuikang (Dalpiciclib Isethionate) | Breast Cancer
Utidelone Injection | Breast Cancer | HongKong DengYue Medicine
Cipterbin (Inetetamab) | Metastatic Breast Cancer | DengYue
Kadcyla (Trastuzumab Emtansine) | Metastatic Breast Cancer | DengYue
Perjeta (Pertuzumab) | Metastatic Breast Cancer | HongKong DengYue
Irene (Pyrotinib) | Breast Cancer | HongKong DengYue Medicine
Ibrance (Palbociclib) | Breast Cancer | HongKong DengYue
Datopotamab Deruxtecan-dlnk | Breast Cancer | HongKong DengYue Medicine
Inavolisib | Metastatic Breast Cancer | HongKong DengYue Medicine
Talzenna (Talazoparib)｜Breast Cancer｜HongKong DengYue Medicine
